Simplex Trading’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Simplex Trading’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15	Closed	-$23K	–	8729
2020 Q1	$23K	Sell	15 -30	-67%	-$485	﹤0.01%	5852
2019 Q4	$73K	Buy	45 +34	+309%	+$567	﹤0.01%	4846
2019 Q3	$16K	Buy	11 +3	+38%	+$40	﹤0.01%	5982
2019 Q2	$13K	Buy	8 +5	+167%	+$82	﹤0.01%	5972
2019 Q1	$5K	Buy	3 +1	+50%	+$18	﹤0.01%	6509
2018 Q4	$3K	Sell	2 -3	-60%	-$51	﹤0.01%	6501
2018 Q3	$9K	Buy	5 +3	+150%	+$62	﹤0.01%	6502
2018 Q2	$3K	Buy	+2	New	+$37	﹤0.01%	6981

Simplex Trading's CBMG Position: Q1 2021 in Review

Simplex Trading sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 26,210 shares.

Simplex Trading first reported a position in CBMG in Q3 2015 and held it in 12 quarters. The position peaked at $65K in Q1 2019. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Simplex Trading reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Simplex Trading sold 26,210 Cellular Biomedicine Group, Inc. shares in Q1 2021.
Simplex Trading first reported a position in Cellular Biomedicine Group, Inc. in Q3 2015 and held it in 12 quarters.
Simplex Trading's Cellular Biomedicine Group, Inc. position peaked at $65K in Q1 2019.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.